QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed

NCT03387111 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Aldoxorubicin HCl
BIOLOGICAL: ETBX-011
BIOLOGICAL: ETBX-021
BIOLOGICAL: ETBX-051
BIOLOGICAL: ETBX-061
BIOLOGICAL: GI-4000
BIOLOGICAL: GI-6207
BIOLOGICAL: GI-6301
BIOLOGICAL: haNK for infusion
DRUG: Avelumab
DRUG: bevacizumab
DRUG: Capecitabine
DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Cyclophosphamide
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: nab-Paclitaxel
DRUG: Necitumumab
PROCEDURE: SBRT

Sponsor

ImmunityBio, Inc.